171 related articles for article (PubMed ID: 10597732)
1. Drug development in prostate cancer.
Ripple GH; Wilding G
Semin Oncol; 1999 Apr; 26(2):217-26. PubMed ID: 10597732
[TBL] [Abstract][Full Text] [Related]
2. Treatment options in hormone-refractory prostate cancer: current and future approaches.
Harris KA; Reese DM
Drugs; 2001; 61(15):2177-92. PubMed ID: 11772129
[TBL] [Abstract][Full Text] [Related]
3. Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC).
Papatsoris AG; Karamouzis MV; Papavassiliou AG
Curr Med Chem; 2005; 12(3):277-96. PubMed ID: 15723619
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors in the treatment of prostate cancer.
Adesunloye BA; Karzai FH; Dahut WL
Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapeutic approaches for hormone-refractory prostate cancer.
Stavridi F; Karapanagiotou EM; Syrigos KN
Cancer Treat Rev; 2010 Apr; 36(2):122-30. PubMed ID: 20106600
[TBL] [Abstract][Full Text] [Related]
6. Novel molecular targets for prostate cancer therapy.
Kamradt JM; Pienta KJ
Semin Oncol; 1999 Apr; 26(2):234-43. PubMed ID: 10597734
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic approaches to advanced prostate cancer.
Armstrong AJ; Carducci MA
Clin Adv Hematol Oncol; 2005 Apr; 3(4):271-82. PubMed ID: 16167000
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.
Ryan CJ; Lin AM; Small EJ
Urol Oncol; 2006; 24(3):250-3. PubMed ID: 16678059
[TBL] [Abstract][Full Text] [Related]
9. New drugs in prostate cancer.
Armstrong AJ; Carducci MA
Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinases as new targets for the prevention and treatment of cancer.
Senderowicz AM
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1229-53. PubMed ID: 12512390
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis as a strategic target for prostate cancer therapy.
Li Y; Cozzi PJ
Med Res Rev; 2010 Jan; 30(1):23-66. PubMed ID: 19536866
[TBL] [Abstract][Full Text] [Related]
12. New agents for prostate cancer.
Reese DM
Hematol Oncol Clin North Am; 2001 Jun; 15(3):547-57. PubMed ID: 11525296
[TBL] [Abstract][Full Text] [Related]
13. A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer.
Liu G; Gandara DR; Lara PN; Raghavan D; Doroshow JH; Twardowski P; Kantoff P; Oh W; Kim K; Wilding G
Clin Cancer Res; 2004 Feb; 10(3):924-8. PubMed ID: 14871968
[TBL] [Abstract][Full Text] [Related]
14. Current trials using bone-targeting agents in prostate cancer.
Tu SM; Lin SH
Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and anti-angiogenic therapy in prostate cancer.
Mukherji D; Temraz S; Wehbe D; Shamseddine A
Crit Rev Oncol Hematol; 2013 Aug; 87(2):122-31. PubMed ID: 23375349
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis inhibitors in the treatment of prostate cancer.
Kluetz PG; Figg WD; Dahut WL
Expert Opin Pharmacother; 2010 Feb; 11(2):233-47. PubMed ID: 20088745
[TBL] [Abstract][Full Text] [Related]
17. Small molecule modulators of cyclin-dependent kinases for cancer therapy.
Senderowicz AM
Oncogene; 2000 Dec; 19(56):6600-6. PubMed ID: 11426645
[TBL] [Abstract][Full Text] [Related]
18. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets of selenium in prostate cancer prevention (Review).
Abdulah R; Kobayashi K; Yamazaki C; Koyama H
Int J Oncol; 2011 Aug; 39(2):301-9. PubMed ID: 21567081
[TBL] [Abstract][Full Text] [Related]
20. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
Ariazi EA; Satomi Y; Ellis MJ; Haag JD; Shi W; Sattler CA; Gould MN
Cancer Res; 1999 Apr; 59(8):1917-28. PubMed ID: 10213501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]